Views & Analysis Genetic testing hopes to speed up drug development in rare e... When it comes to fighting rare diseases, the biggest barrier to overcome is often the lack of knowledge around the condition.
News UK Knowledge Quarter welcomes Boehringer Ingelheim AI accele... Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.